Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The goal of this study is to use [C-11]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls
Full description
This study seeks to examine dopamine (DA) transmission in vivo, using positron emission tomography (PET) with [C-11]FLB 457, in cortical regions of interest in subjects who have a history of cocaine dependence. We hypothesize that cocaine dependence is associated with decreases in dopamine in the prefrontal cortical regions compared to controls. This may explain the impulsivity and cognitive deficits that underlie relapse in this disorder.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Subjects with Cocaine Dependence INCLUSION CRITERIA
Males or Females 18-40
Fulfill Diagnostic and Statistical Manual (DSM-IV) Diagnosis for Cocaine Dependence
Medically Healthy MAJOR EXCLUSIONS
Major medical, psychiatric, co-morbid drug & alcohol use disorders 2. Pregnancy or lactation, 3. Contraindications to MRI 4. Currently employed as radiation worker; or participation in radioactive drug research protocols within the previous year 5. Family History of a psychotic illness or manic episode in first-degree relatives
Healthy Subjects INCLUSION CRITERIA
MAJOR EXCLUSIONS
Primary purpose
Allocation
Interventional model
Masking
30 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal